文献速递慢性肾脏病

抑郁症状与CKD患者种族及全因死亡率的关联

Depressive Symptoms Associate With Race and All-Cause Mortality in Patients With CKD.
PubMed 文献 · Kidney Int Rep · 2018-10-09

在CRIC队列3739例轻中度CKD患者中,基线BDI>14与全因死亡率升高独立相关(aHR 1.27, 95%CI 1.07-1.52),抗抑郁药使用未减弱此关联。该关联存在种族差异(P交互=0.02),仅白人显著(aHR 1.66, 95%CI 1.21-2.28),黑人和西班牙裔不显著。AASK队列611例结果类似。

要点

  • CKD患者基线抑郁症状(BDI>14)与全因死亡风险增加27%独立相关。
  • 抑郁症状与死亡率的关联存在种族差异,仅白人中显著。
  • 抗抑郁药使用未减弱抑郁症状与死亡率的关联。

核心结论

  • 抑郁症状是轻中度CKD患者全因死亡的危险因素,尤其在白人中显著。

研究设计与样本

  • 基于CRIC队列3739例轻中度CKD患者的前瞻性分析,中位随访6.8年,并在AASK队列611例中验证。

主要发现

  • CRIC队列中16.3%基线BDI>14,18.2%使用抗抑郁药,粗死亡率为3.16/100人年。
  • 基线BDI>14与全因死亡率升高独立相关(aHR 1.27; 95%CI 1.07-1.52),抗抑郁药使用未减弱关联。
  • 种族交互显著(P交互=0.02):白人aHR 1.66(95%CI 1.21-2.28),黑人aHR 1.06(0.82-1.37),西班牙裔aHR 1.47(0.95-2.28)。
  • AASK队列中抑郁症状与死亡率关联不显著(aHR 0.99; 95%CI 0.69-1.42)。

关键数值与推荐

  • 抑郁症状定义为基线BDI评分>14。
  • 模型调整社会经济因素、基线CKD严重程度、时变合并症和时变抗抑郁药使用。

临床怎么用

  • 在轻中度CKD患者中应识别抑郁症状(BDI>14),尤其白人患者,因其与死亡风险升高相关。
  • 抗抑郁药使用未改变抑郁症状与死亡率的关联,需进一步研究。

局限性

  • 研究为观察性设计,不能确定因果关系。
  • 抑郁症状仅在基线评估,未反映动态变化。
  • 种族差异机制未明,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Depression is common but underrecognized in patients with chronic kidney disease (CKD), especially among racial/ethnic minorities. We examined the association between depressive symptoms and all-cause mortality (including deaths before and after end-stage renal disease [ESRD]) and whether antidepressant use impacts this association, overall, and by race/ethnicity. METHODS: We ascertained whether the presence of depressive symptoms, defined by a Beck Depression Inventory II (BDI) score of >14 at cohort enrollment, was associated with all-cause mortality (before or after ESRD) among study participants of the Chronic Renal Insufficient Cohort (CRIC) overall and by race/ethnicity. Models were adjusted for socioeconomic factors, baseline CKD severity, time-updated comorbid conditions, and time-updated antidepressant use. Confirmatory analyses were performed among African American Study of Kidney Disease and Hypertension (AASK) participants. RESULTS: Among 3739 CRIC participants, 16.3% had a baseline BDI of >14; 18.2% reported antidepressant use. Crude mortality rate was 3.16 per 100 person-years during 6.8 years of median follow-up. Baseline BDI >14 was independently associated with higher risk of all-cause mortality (adjusted hazard ratio [aHR]: 1.27; 95% confidence interval: 1.07-1.52) without attenuation by antidepressant use. Differences among white and black individuals were noted (Pinteraction= 0.02) but not among white versus Hispanic individuals (Pinteraction = 0.43) or black versus Hispanic individuals (Pinteraction = 0.22). Depressive symptoms were associated with higher mortality among white individuals (aHR: 1.66; 1.21-2.28), but not Hispanic individuals (aHR: 1.47; 0.95-2.28) or black individuals (aHR: 1.06; 0.82-1.37). Similar results were noted among 611 AASK participants (aHR: 0.99; 0.69-1.42). CONCLUSIONS: The presence of depressive symptoms is a risk factor for all-cause mortality among patients with mild-moderate CKD, particularly among white individuals. Further studies are needed to understand the heterogeneity in the response to the presence of depressive symptoms by race.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Tuot DS, Lin F, Norris K, et al. Depressive Symptoms Associate With Race and All-Cause Mortality in Patients With CKD. Kidney Int Rep. 2018. PMID: 30775619. doi:10.1016/j.ekir.2018.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。